Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia.

Cancer Cell biology Immune system disorder Immunology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
19 Aug 2022
Historique:
received: 05 05 2022
revised: 16 06 2022
accepted: 25 07 2022
entrez: 22 8 2022
pubmed: 23 8 2022
medline: 23 8 2022
Statut: epublish

Résumé

Waldenström macroglobulinemia (WM) is characterized by bone marrow infiltration with malignant lymphoplasmacytic cells (LPCs), a smaller population of plasma cells (PCs), and hypersecretion of IgM monoclonal protein. Here, we show that CD45

Identifiants

pubmed: 35992066
doi: 10.1016/j.isci.2022.104856
pii: S2589-0042(22)01128-2
pmc: PMC9389254
doi:

Types de publication

Journal Article

Langues

eng

Pagination

104856

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests relevant to this manuscript. DT has received research funding from Janssen and Roche, and honoraria from CSL, Takeda, Roche, Janssen, Beigene, and EUSA.

Références

Blood. 2012 Mar 8;119(10):2205-8
pubmed: 22147890
N Engl J Med. 2018 Apr 12;378(15):1396-1407
pubmed: 29641966
Blood. 2014 May 1;123(18):2791-6
pubmed: 24553177
Blood. 2013 Aug 15;122(7):1256-65
pubmed: 23699601
Am J Clin Pathol. 2005 Feb;123(2):200-5
pubmed: 15842043
Nat Genet. 2011 Jul 31;43(9):830-7
pubmed: 21804550
Blood. 2013 Mar 28;121(13):2522-8
pubmed: 23355535
Leukemia. 2007 Sep;21(9):2043-6
pubmed: 17460704
Curr Treat Options Oncol. 2017 Jul;18(7):45
pubmed: 28670664
Nat Immunol. 2001 Dec;2(12):1103-8
pubmed: 11725300
Cancer Res. 2011 Nov 1;71(21):6718-27
pubmed: 21900401
Blood. 2013 Mar 14;121(11):2051-8
pubmed: 23321251
Blood. 2014 Mar 13;123(11):1637-46
pubmed: 24366360
J Biol Chem. 2003 Oct 17;278(42):41443-51
pubmed: 12888566
Clin Lymphoma Myeloma. 2009 Mar;9(1):36-8
pubmed: 19362968
Semin Thromb Hemost. 2003 Oct;29(5):467-71
pubmed: 14631546
Semin Oncol. 2003 Apr;30(2):110-5
pubmed: 12720118
Mol Cancer Ther. 2016 Aug;15(8):1781-91
pubmed: 27413114
Blood. 1997 Aug 1;90(3):1109-14
pubmed: 9242542
Cytometry B Clin Cytom. 2011 Sep;80(5):318-23
pubmed: 21634008
Ann Hematol. 2017 Jun;96(6):971-976
pubmed: 28280994
Nature. 2018 Aug;560(7718):387-391
pubmed: 29925955
Leukemia. 2015 Jan;29(1):169-76
pubmed: 24912431
J Clin Oncol. 2003 Nov 1;21(21):3940-7
pubmed: 12975461
N Engl J Med. 2015 Aug 6;373(6):584-6
pubmed: 26244327
Blood. 2020 May 14;135(20):1759-1771
pubmed: 32187361
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
Cytometry B Clin Cytom. 2021 Jul;100(4):497-508
pubmed: 33017079
Clin Cancer Res. 2016 Mar 15;22(6):1480-8
pubmed: 26490317
J Clin Pathol. 2011 Jun;64(6):520-3
pubmed: 21471142
Br J Haematol. 2011 Jul;154(2):223-8
pubmed: 21564078
Nature. 2010 Jun 17;465(7300):885-90
pubmed: 20485341
Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):96-8
pubmed: 21454202
Haematologica. 2013 Apr;98(4):649-54
pubmed: 23065509
Nature. 2011 Feb 3;470(7332):115-9
pubmed: 21179087
Lab Invest. 2016 May;96(5):517-25
pubmed: 26878134
Mol Cancer. 2018 Feb 19;17(1):57
pubmed: 29455639
Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):211-3
pubmed: 23523273
Pathology. 2017 Jun;49(4):337-345
pubmed: 28483372
N Engl J Med. 2012 Aug 30;367(9):826-33
pubmed: 22931316
Leukemia. 2014 Aug;28(8):1698-704
pubmed: 24509637
Blood. 2012 Aug 16;120(7):1466-9
pubmed: 22760778
Science. 1997 Nov 28;278(5343):1612-5
pubmed: 9374458
Mod Pathol. 2009 Jun;22(6):807-16
pubmed: 19287458
J Mol Diagn. 2005 Aug;7(3):346-51
pubmed: 16049306
Leukemia. 2013 Jan;27(1):183-9
pubmed: 22944768
Blood. 1998 Apr 15;91(8):3007-10
pubmed: 9531613
Br J Haematol. 2017 Jun;177(5):717-725
pubmed: 28485115
Blood. 2011 May 12;117(19):e190-7
pubmed: 21415268
Nat Rev Cancer. 2014 Apr;14(4):219-32
pubmed: 24658273
JAMA. 1965 May 10;192:464-7
pubmed: 14284847
Br J Haematol. 2017 Mar;176(5):822-824
pubmed: 26936399
Int J Mol Sci. 2021 May 27;22(11):
pubmed: 34071917
Haematologica. 2017 Dec;102(12):2077-2085
pubmed: 28983055
Br J Haematol. 2015 Jun;169(6):795-803
pubmed: 25819228

Auteurs

Jun Hee Lim (JH)

Haematology Translational Research Unit, Canberra Hospital, Canberra, Australia.
ANU Medical School, College of Medicine and Health, Australian National University, Canberra, Australia.
Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.

James Q Wang (JQ)

ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.

Fiona Webb (F)

Department of Diagnostic Genomics, ACT Pathology, Canberra, Australia.

Kartik Saxena (K)

Haematology Translational Research Unit, Canberra Hospital, Canberra, Australia.

Daniel Enosi Tuipulotu (D)

Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.

Abhimanu Pandey (A)

Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.

Si Ming Man (SM)

Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.

Dipti Talaulikar (D)

Haematology Translational Research Unit, Canberra Hospital, Canberra, Australia.
ANU Medical School, College of Medicine and Health, Australian National University, Canberra, Australia.
Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.

Classifications MeSH